Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 66

Vectura provides update on GSK litigation

Published13/09/2019

Read more
Vectura delivers strong H1 2019 financial performance

Published10/09/2019

Read more
Proposed increased capital return to shareholders of approx. £60m

Published09/09/2019

Read more
Proposed £50 million capital return and trading update

Published17/07/2019

Read more
Vectura Group Plc announces leadership changes

Published10/06/2019

Read more
QVM149 submission means early $2.5m payment for Vectura

Published24/05/2019

Read more
Vectura data to be shared at ATS 2019

Published15/05/2019

Read more
Vectura wins US GSK patent litigation and awarded $89.7m in damages by jury

Published26/04/2019

Read more
R&D: Transformation frees up more resources for innovation

Published10/04/2019

Read more
Vectura reports strong 2018 financial and operational performance

Published26/03/2019

Read more
Pre-close trading update confirms good progress against 2018 goals

Published03/01/2019

Read more
Global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio

Published08/11/2018

Read more

Displaying 12 of 66